
Genetic Technologies Limited GENE
Geschäftsbericht 2022
hinzugefügt 30.08.2022
Genetic Technologies Limited Kurshistorie 2011-2026 | GENE
Kurshistorie Jährlich Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.44 | 2.07 | 4.37 | 2.79 | 3.44 | 5.76 | 4.4 | 8.24 | 23.3 | 32.8 | 49 | 63.6 |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 63.6 | 1.44 | 16.8 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
3.13 | $ 2.13 | - | $ 4.89 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 74.43 | -1.72 % | $ 5.02 B | ||
|
Charles River Laboratories International
CRL
|
155 | $ 158.47 | 0.24 % | $ 7.85 B | ||
|
IQVIA Holdings
IQV
|
165 | $ 165.48 | -0.92 % | $ 28.4 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 457.54 | 0.13 % | $ 13.2 B | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
1.46 | $ 1.21 | -17.14 % | $ 6.59 M | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 243.86 | 0.28 % | $ 25.6 B | ||
|
Interpace Biosciences
IDXG
|
0.94 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
636 | $ 571.85 | -1.15 % | $ 46 B | ||
|
Illumina
ILMN
|
103 | $ 125.07 | 1.03 % | $ 19.9 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 100.54 | 0.19 % | $ 8.29 B | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 4.68 | 0.54 % | $ 433 M | ||
|
Guardant Health
GH
|
107 | $ 83.91 | -1.17 % | $ 10.5 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
National Research Corporation
NRC
|
14.1 | $ 17.51 | - | $ 392 M | ||
|
Pacific Biosciences of California
PACB
|
1.66 | $ 1.36 | -2.52 % | $ 408 M | ||
|
Celcuity
CELC
|
10.1 | $ 101.4 | -5.01 % | $ 4 B | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 263.49 | -0.37 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
6.7 | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
ENDRA Life Sciences
NDRA
|
4.1 | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 7.93 | -2.1 % | $ 1.02 B | ||
|
Personalis
PSNL
|
4.28 | $ 7.52 | -1.18 % | $ 446 M | ||
|
Natera
NTRA
|
53.9 | $ 194.93 | -2.58 % | $ 19.2 B | ||
|
RadNet
RDNT
|
74.8 | $ 59.45 | -3.72 % | $ 4.47 B | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 17.37 | -1.08 % | $ 926 M | ||
|
OPKO Health
OPK
|
1.75 | $ 1.14 | -1.3 % | $ 791 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 25.36 | -1.51 % | $ 704 M | ||
|
Senseonics Holdings
SENS
|
8.4 | $ 6.71 | 1.36 % | $ 280 M | ||
|
Sotera Health Company
SHC
|
16.7 | $ 13.8 | -0.61 % | $ 3.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 195.47 | -0.08 % | $ 21.7 B | ||
|
DarioHealth Corp.
DRIO
|
8.24 | $ 7.37 | -1.73 % | $ 29.4 M | ||
|
DexCom
DXCM
|
65.4 | $ 66.5 | 0.85 % | $ 25.9 B |